A non-interventional, observational, cross-sectional study to assess the impact of Parkinson's disease on quality of life of Parkinson's disease patients and their caregivers in Japan.

A non-interventional, observational, cross-sectional study to assess the impact of Parkinson's disease on quality of life of Parkinson's disease patients and their caregivers in Japan. - A cross-sectional study to assess the impact of PD on QOL of PD patients and their caregivers in Japan.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000028490

Enrollment

2000

Registered

2017-08-14

Start date

2017-08-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson&#39

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients, who fulfill the following selection criteria, can be included: - Adult patients with confirmed diagnosis of idiopathic Parkinson's disease - Willingness and ability to provide informed consent Caregivers, who fulfill the following selection criteria, can be included: - Caregivers who are currently taking care of adult patients with confirmed diagnosis of idiopathic Parkinson's disease - Willingness and ability to provide informed consent

Exclusion criteria

Exclusion criteria: Information from caregivers of patients who have not provided informed consent will not be included.

Design outcomes

Primary

Measure	Time frame
The primary endpoint is PDQ-8 summary index score, PDQ-8 SI. The primary indicator of PD severity is off-time period per day. The secondary indicators of PD severity are original H&Y stage, presence of wearing-off (WOQ-9 score), troublesome dyskinesia period per day, motor symptoms (SE-ADL score) and NMS (NMSQ total score).	—

Secondary

Measure	Time frame
The secondary endpoints are as follows: - EQ-5D-5L index value - PDQ-carer summary index, PDQ-carer SI	—

Countries

Japan

Contacts

Public ContactJun Watanabe

AbbVie GK Medical Affairs

jun.watanabe@abbvie.com080-3444-1687

Outcome results